1-4 of 4
Kerstin Wittke
Close
Sort by
Journal Articles

Polymorphisms of Exon 10 in Stem Cell Factor Receptor KIT Are Associated with a Significantly Improved Relapse-Free Survival in Childhood AML.

Muriel Malaise, PhD, Juan Du, MD, Beate Junk, Kerstin Wittke, Martin Zimmermann, PhD, Dirk Reinhardt, MD, PhD, Konstanze Doehner, MD, Klaus-Michael Debatin, MD, Selim Corbacioglu, MD
Journal: Blood
Blood (2009) 114 (22): 2636.
https://doi.org/10.1182/blood.V114.22.2636.2636
Published: 2009
Journal Articles

Insertion of FLT3 internal tandem duplication in the tyrosine kinase domain-1 is associated with resistance to chemotherapy and inferior outcome

Clinical Trials & Observations
Sabine Kayser, Richard F. Schlenk, Martina Correa Londono, Frank Breitenbuecher, Kerstin Wittke, Juan Du, Silja Groner, Daniela Späth, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Thomas Fischer, Konstanze Döhner, for the German-Austrian AML Study Group (AMLSG)
Journal: Blood
Blood (2009) 114 (12): 2386–2392.
https://doi.org/10.1182/blood-2009-03-209999
Published: 2009
Journal Articles

Prognostic Implication of Insertion of FLT3 Internal Tandem Duplication in the BETA-1-Sheet of the Tyrosine Kinase Domain-1

Sabine Kayser, Richard F. Schlenk, Frank Breitenbücher, Martina Porebski, Kerstin Wittke, Juan Du, Silja Groner, Daniela Spaeth, Jürgen Krauter, Arnold Ganser, Hartmut Döhner, Thomas Fischer, Konstanze Döhner
Journal: Blood
Blood (2008) 112 (11): 2514.
https://doi.org/10.1182/blood.V112.11.2514.2514
Published: 2008
Journal Articles

RUNX1 Mutations in Acute Myeloid Leukemia (AML): Correlation with Distinct Cytogenetic Subgroups and Clinical Outcome. Results of the AML Study Group (AMLSG)

Verena I. Gaidzik, MD, Richard F. Schlenk, MD, Kerstin Wittke, Annegret Becker, Andreas Zimmermann, Brigitte Schlegelberger, MD, Arnold Ganser, MD, PhD, Daniela Spaeth, Hartmut Doehner, MD, Konstanze Doehner, MD
Journal: Blood
Blood (2008) 112 (11): 145.
https://doi.org/10.1182/blood.V112.11.145.145
Published: 2008